烟草和酒精公司应该被允许影响澳大利亚的国家毒品战略吗？
Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?
作者信息
Freeman Becky, MacKenzie Ross, Daube Mike
机构信息
School of Public Health, University of Sydney, NSW, Australia,
Department of Psychology, Macquarie University, Sydney, NSW, Australia.
出版信息
Public Health Res Pract. 2017 Apr 27;27(2):2721714. doi: 10.17061/phrp2721714.
Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.
澳大利亚国家毒品战略（NDS）的制定过程包括广泛的咨询，不仅向社区和公共卫生利益相关者开放，也向烟草和酒精行业的代表开放。澳大利亚受世界卫生组织《烟草控制框架公约》的约束，该公约要求各国政府保护烟草控制措施不受烟草行业干扰。这些存在利益冲突的行业提交给NDS的咨询意见并未公开以供审查。NDS的目标与那些支持监管停滞、反对并破坏有效行动、忽视和歪曲证据且将利润置于健康之上的行业的商业议程背道而驰。
Zotero 插件